MDMX contains an autoinhibitory sequence element

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 44, 2013, Pages 17814-17819

  Bista, Michal ^a   Petrovich, Miriana ^a   Fersht, Alan R ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN MDMX;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN STRUCTURE;

HDMX; IDP; MDM4; MDMX-S; TROSY;

CALORIMETRY; CHROMATOGRAPHY, GEL; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEAR PROTEINS; ONCOGENES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; ULTRACENTRIFUGATION;

EID: 84887074375     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317398110     Document Type: Article

References (43)

1. Garcia D, et al. (2011) Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev 25(16):1746-1757.
2. Lenos K, Jochemsen AG (2011) Functions of MDMX in the modulation of the p53- response. J Biomed Biotechnol 2011:876173.
3. Wade M, Li YC, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13(2):83-96.
4. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275(12): 8945-8951.
5. Gembarska A, et al. (2012) MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 18(8):1239-1247.
6. Linares LK, Hengstermann A, Ciechanover A, Müller S, Scheffner M (2003) HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc Natl Acad Sci USA 100(21):12009-12014.
7. Kussie PH, et al. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274(5289):948-953.
8. Popowicz GM, Czarna A, Holak TA (2008) Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain. Cell Cycle 7(15): 2441-2443.
9. Schon O, Friedler A, Bycroft M, Freund SM, Fersht AR (2002) Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol 323(3):491-501.
10. Czarna A, et al. (2010) Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists. Angew Chem Int Ed Engl 49(31):5352-5356.
11. Yu GW, Allen MD, Andreeva A, Fersht AR, Bycroft M (2006) Solution structure of the C4 zinc finger domain of HDM2. Protein Sci 15(2):384-389.
12. Linke K, et al. (2008) Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ 15(5): 841-848.
13. Kostic M, Matt T, Martinez-Yamout MA, Dyson HJ, Wright PE (2006) Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J Mol Biol 363(2):433-450.
14. Vassilev LT, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659):844-848.
15. Wade M, Wahl GM (2009) Targeting Mdm2 and Mdmx in cancer therapy: Better living through medicinal chemistry? Mol Cancer Res 7(1):1-11.
16. Hu B, Gilkes DM, Farooqi B, Sebti SM, Chen J (2006) MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin. J Biol Chem 281(44):33030-33035.
17. Kawai H, Lopez-Pajares V, Kim MM, Wiederschain D, Yuan ZM (2007) RING domainmediated interaction is a requirement for MDM2's E3 ligase activity. Cancer Res 67(13):6026-6030.
18. Yu GW, et al. (2006) The central region of HDM2 provides a second binding site for p53. Proc Natl Acad Sci USA 103(5):1227-1232.
19. Robson AF, et al. (2012) Nanosensing protein allostery using a bivalent mouse double minute two (MDM2) assay. Proc Natl Acad Sci USA 109(21):8073-8078.
20. Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL (2006) Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 23(2):251-263.
21. Shloush J, et al. (2011) Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2. J Biol Chem 286(6):4796-4808.
22. Li P, et al. (2012) Phase transitions in the assembly of multivalent signalling proteins. Nature 483(7389):336-340.
23. Wang X, Wang J, Jiang X (2011) MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J Biol Chem 286(27):23725-23734.
24. Bocharov EV, et al. (2004) From structure and dynamics of protein L7/L12 to molecular switching in ribosome. J Biol Chem 279(17):17697-17706.
25. Bista M, Freund SM, Fersht AR (2012) Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy. Proc Natl Acad Sci USA 109(39):15752-15756.
26. Shan B, Li DW, Brüschweiler-Li L, Brüschweiler R (2012) Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: Implications for regulating the p53MDM2/MDMX interaction. J Biol Chem 287(36):30376-30384.
27. Rallapalli R, Strachan G, Cho B, Mercer WE, Hall DJ (1999) A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity. J Biol Chem 274(12):8299-8308.
28. Trudeau T, et al. (2013) Structure and intrinsic disorder in protein autoinhibition. Structure 21(3):332-341.
29. Lenos K, et al. (2012) Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. Cancer Res 72(16): 4074-4084.
30. Liu L, et al. (2012) S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia. Cancer Sci 103(12):2056-2063.
31. Lane DP, et al. (2011) Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish. Cell Cycle 10(24):4272-4279.
32. Wu S, Chen L, Becker A, Schonbrunn E, Chen J (2012) Casein kinase 1 regulates an MDMX intramolecular interaction to stimulate p53 binding. Mol Cell Biol 32(23): 4821-4832.
33. Chen L, Li C, Pan Y, Chen J (2005) Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol 25(15):6509-6520.
34. Dümmler A, Lawrence AM, de Marco A (2005) Simplified screening for the detection of soluble fusion constructs expressed in E. coli using a modular set of vectors. Microb Cell Fact 4:34.
35. Nikolova PV, Henckel J, Lane DP, Fersht AR (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc Natl Acad Sci USA 95(25):14675-14680.
36. Some D (2013) Light-scattering-based analysis of biomolecular interactions. Biophys Rev 5(2):147-158.
37. Czarna A, et al. (2009) High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx. Cell Cycle 8(8):1176-1184.
38. Pervushin K, Riek R, Wider G, Wüthrich K (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci USA 94(23):12366-12371.
39. Mori S, Abeygunawardana C, Johnson MO, van Zijl PC (1995) Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B 108(1):94-98.
40. Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog Nucl Magn Reson Spectrosc 34(2):93-158.
41. Zhang O, Kay LE, Olivier JP, Forman-Kay JD (1994) Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques. J Biomol NMR 4(6): 845-858.
42. Kay LE, Torchia DA, Bax A (1989) Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease. Biochemistry 28(23):8972-8979.
43. Markson G, et al. (2009) Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res 19(10):1905-1911.